AKT1 and hyperkeratosis lenticularis perstans: These pathways are highly involved in YLTZC treatment of HLP, among which the PI3K-Akt signaling pathway, PPAR signaling pathway, and IR play critical roles in insulin secretion and lipid metabolism.